Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: Lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study

Liesbeth de Wreede (1, 2) , Maggie Watson , Marleen van Os , Donald Milligan , Michel van Gelder , Michal Michallet , Peter Dreger , Claire E. Dearden , Janis Sutton , Jehan Dupuis , Michel M. Leporrier (3) , Michal Karas , Bernadette Corront , Gabriela M. Baerlocher , Johannes Herr , Sylvain Choquet , Dietger W. Niederwieser , Laurent Sutton , Nicolaus Kröger , Theo M. de Witte , Johannes Schetelig

1 Dept. of Medical Statistics
2 EBMT - European Society for Blood and Marrow Transplantation
3 LDM-TEP - Laboratoire de Développements Méthodologiques en Tomographie par Emission de Positons

Domaines: Sciences du Vivant [q-bio]

Liesbeth de Wreede, Maggie Watson, Marleen van Os, Donald Milligan, Michel van Gelder, et al.. Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: Lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study. American Journal of Hematology, 2014, 89 (2), pp.174 - 180. ⟨10.1002/ajh.23610⟩. ⟨hal-01629190⟩